Showing results (1-10 of 388) with videos related to
Sort By:
Pageof 39
Lung Cancer (Amsterdam, Netherlands)|January 9, 2007
Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesisBirgitte Vrou Offersen, Per Pfeiffer, Peter Andreasen, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 18, 2002
Comparison of methods of microvascular staining and quantification in prostate carcinoma: relevance to prognosisBirgitte Vrou Offersen, Michael Borre, Flemming Brandt Sørensen, et al.Breast (Edinburgh, Scotland)|October 1, 2013
Is regional nodes radiotherapy an alternative to surgery?Birgitte Vrou Offersen, Hanne Melgaard Nielsen, Marie Overgaard, et al.Acta Oncologica (Stockholm, Sweden)|July 27, 2007
Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancerBirgitte Vrou Offersen, Rikke Riisbro, Ann Knoop, et al.Acta Oncologica (Stockholm, Sweden)|May 10, 2008
A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patientsJan Alsner, Vibeke Jensen, Marianne Kyndi, et al.The American Journal of Pathology|October 28, 2003
The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomasBirgitte Vrou Offersen, Boye Schnack Nielsen, Gunilla Høyer-Hansen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 15, 2022
Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trialMarie Overgaard, Hanne Melgaard Nielsen, Trine Tramm, et al.Acta Oncologica (Stockholm, Sweden)|December 6, 2017
Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaborationBent Ejlertsen, Birgitte Vrou Offersen, Jens Overgaard, et al.Breast (Edinburgh, Scotland)|July 9, 2025
Prognostic value of tumor-infiltrating lymphocytes in irradiated node-positive breast cancer patientsDemet Özcan, Anders Winther Mølby Nielsen, Jan Alsner, et al.Pageof 39